The FDA approves two new pancreatic enzyme products marketed by privately-held Aptalis Pharma....

|By:, SA News Editor

The FDA approves two new pancreatic enzyme products marketed by privately-held Aptalis Pharma. The treatments are used to aid food digestion for patients with cystic fibrosis.